Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
2.740
-0.070 (-2.49%)
At close: Oct 13, 2025, 4:00 PM EDT
2.740
0.00 (0.00%)
After-hours: Oct 13, 2025, 4:10 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $66.93 million as of October 13, 2025. Its market cap has decreased by -81.76% in one year.
Market Cap
66.93M
Enterprise Value
-60.50M
1-Year Change
-81.76%
Ranking
Category
Stock Price
$2.74
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has decreased from $176.76M to $66.93M, a decrease of -62.14%. That is a compound annual growth rate of -54.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 68.64M | -71.97% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |